BOTHELL, Wash., March 11 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, today announced that it will present at the Washington Biotechnology and Biomedical Association (WBBA) 2009 Invest Northwest CEO and Investor Forum at the Bell Harbor International Conference Center in Seattle. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results, during the Company's presentation on Wednesday, March 18 at 9:40 a.m. local time.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)
Attendance at the conference is by invitation only. Cardiac Science will offer a live webcast of its presentation, which may be accessed at the Company's website at www.cardiacscience.com. An archived replay of the presentation will also be available following the live presentation and can be accessed at www.cardiacscience.com for 90 days.
About Cardiac Science
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For more information,
Company Contact: Investor Contact: Media Contact:
Mike Matysik Doug Sherk Christopher Gale
Cardiac Science Corporation Jenifer Kirtland EVC Group Inc.
Senior Vice President and CFO EVC Group Inc. 646.201.5431
425.402.2009 415.896.6820 203.570.4681
cgale@evcgroup.com
CSCX-F
'/>"/>
| SOURCE Cardiac Science Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Antidepressant Use Tied to Cardiac Death in Women
2. The Larry King Cardiac Foundation Brings its Annual Gala to Homes Across the Nation
3. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in Nation to Use NaviStar(R) RMT ThermoCool(R) Catheter Since Technology Received FDA Approval
4. Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call
5. Landmark Trial Provides Vital Information for Cardiac Disease Treatment
6. Cardiac Science to Present at the Roth 21st Annual OC Growth Stock Conference
7. Sudden Cardiac Death Rare in Young Athletes
8. Global Economic Meltdown - Is the European Cardiac Rhythm Management Market Spared?
9. TV News Coverage Reports on InnerCools CoolBlue System Treatment of Cardiac Shock Patient Following Childbirth at Rush Hospital, Chicago
10. Worlds First Cardiac Adult Stem Cell Trial to Take Place in Louisville
11. iCardiac's Highly Automated QT(sm) Technology Now Validated in Over 10 Clinical QT Studies
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |